Hoi-Yoon Jung
Directeur Général chez NOVMETAPHARMA CO., LTD.
Postes actifs de Hoi-Yoon Jung
Sociétés | Poste | Début | Fin |
---|---|---|---|
NOVMETAPHARMA CO., LTD. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Directeur Technique/Scientifique/R&D | - | - | |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Directeur/Membre du Conseil | - | - |
Directeur Technique/Scientifique/R&D | - | - | |
Pohang University of Science & Technology | Corporate Officer/Principal | 01/01/2019 | - |
Historique de carrière de Hoi-Yoon Jung
Formation de Hoi-Yoon Jung
Handong Global University | Graduate Degree |
Pohang University of Science & Technology | Doctorate Degree |
Statistiques
Internationale
Corée du Sud | 5 |
Opérationnelle
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Bourse
- Insiders
- Hoi-Yoon Jung
- Expérience